California Institute for Biomedical Research

HitGen partners with Scripps Research Institute and Calibr

Monday, April 24, 2017

HitGen, a privately held biotech company focused on technology for effective and efficient small molecule drug discovery and development, announced a collaboration with The Scripps Research Institute (TSRI) and its affiliate, the California Institute for Biomedical Research (Calibr). This collaboration is to discover and develop potential new therapies in areas of unmet clinical need, with an initial focus in oncology, regenerative medicine and virology.

[Read More]

The Scripps Research Institute, California Institute for Biomedical Research sign affiliation to accelerate the development of new medicines

Wednesday, October 26, 2016

The Scripps Research Institute (TSRI) and the California Institute for Biomedical Research (Calibr) two leading non-profit research organizations announced the signing of a strategic affiliation that combines the two organizations into a new biomedical research entity with the tools and know-how to rapidly translate its scientific discoveries into life-saving medicines for the public benefit.

[Read More]